Skip to main content
Print Save

Ibrance Prices, Coupons and Patient Assistance Programs

Ibrance (palbociclib) is a member of the CDK 4/6 inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Male, Breast Cancer - Metastatic, and others.

The cost for Ibrance oral capsule 75 mg is around $15,886 for a supply of 21 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Ibrance is available as a brand name drug only, a generic version is not yet available. View generic Ibrance availability for more details.

Ibrance prices

Oral Capsule

Oral Tablet

Ibrance Coupons, Copay Cards and Rebates

Ibrance offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Ibrance Pfizer Oncology Together Co-pay Savings Program (oral products)

Eligible commercially insured patients may pay as little as $0 per prescription with savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.

Applies to:
Ibrance
Number of uses:
12 times within calendar year
Expires
December 31, 2023

Form more information phone: 877-744-5675 or Visit website

Ibrance Pfizer Oncology Together Co-Pay Savings Program Rebate (oral products)

Eligible commercially insured patients may submit a request for a rebate in connection with this offer if their pharmacy does not participate in the program; for additional information contact the program at 877-744-5675.

Applies to:
Ibrance
Number of uses:
One rebate per prescription fill
Expires
December 31, 2023

Form more information phone: 877-744-5675 or Visit website

Healthcare professionals may obtain a voucher for a free 1-month (21-day) trial of Ibrance for their new patients to begin treatment.

Applies to:
Ibrance
Number of uses:
One-time offer
Expires
December 31, 2023

Form more information phone: 877-744-5675 or Visit website

Healthcare professionals may samples of Ibrance for their practice by contacting their Pfizer representative at 877-744-5675.

Applies to:
Ibrance
Number of uses:
Per length of program

Form more information phone: 877-744-5675 or Visit website

Ibrance Medicare Part D Extra Help Subsidy

Patients who have Medicare Part D coverage may be eligible to apply for the Part D Extra Help Subsidy and once accepted to the program may receive reduced premiums and lower prescription costs; contact the program directly for questions or to sign-up.

Applies to:
Ibrance
Number of uses:
Per prescription until program expires

Form more information phone: 800-772-1213 or Visit website

Patient Assistance & Copay Programs for Ibrance

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Pfizer RxPathways

Eligibility requirements:
  1. Contact program for details.
  2. Varies
  3. FDA-approved diagnosis
  4. Must be residing in the US or US territory
  5. Co-payment assistance, and patient assistance programs are available for eligible patients. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Ibrance (palbociclib) Capsule

More information please phone: 844-989-7284 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Ibrance (palbociclib)

More information please phone: 866-316-7263 Visit Website

Provider: Pfizer Oncology Together

Eligibility requirements:
  1. Contact program for details.
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be under treatment from a US doctor.
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Ibrance (palbociclib)

More information please phone: 877-744-5675 Visit Website